Bioharvest Sciences Inc (BHST)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
6.26 -0.29 (-4.43%) 04/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 6.26 unch (unch) 15:59 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -12,913 | -12,564 | -11,236 | -9,827 | -6,584 |
Depreciation Amortization | 1,251 | 840 | 712 | 389 | 288 |
Accounts receivable | -594 | -22 | -588 | -266 | -73 |
Other Working Capital | -555 | 755 | -308 | -96 | -232 |
Other Operating Activity | 6,127 | 2,469 | 2,179 | 3,006 | 2,726 |
Operating Cash Flow | $-6,684 | $-8,522 | $-9,241 | $-6,794 | $-3,875 |
Cash Flows From Investing Activities | |||||
PPE Investments | -2,835 | -1,474 | -1,256 | -1,640 | -173 |
Other Investing Activity | -192 | 0 | 0 | 0 | 0 |
Investing Cash Flow | $-3,027 | $-1,474 | $-1,256 | $-1,640 | $-173 |
Cash Flows From Financing Activities | |||||
Debt Issued | 3,314 | 13,517 | 7,658 | N/A | 769 |
Debt Repayment | -693 | N/A | N/A | N/A | N/A |
Common Stock Issued | 4,738 | 403 | 877 | 11,104 | 4,469 |
Other Financing Activity | -579 | -364 | -397 | -332 | -312 |
Financing Cash Flow | $6,780 | $13,556 | $8,138 | $10,772 | $4,926 |
Exchange Rate Effect | -34 | 59 | -22 | -4 | -6 |
Beginning Cash Position | 5,355 | 1,736 | 4,117 | 1,783 | 911 |
End Cash Position | 2,390 | 5,355 | 1,736 | 4,117 | 1,783 |
Net Cash Flow | $-2,965 | $3,619 | $-2,359 | $2,334 | $872 |
Free Cash Flow | |||||
Operating Cash Flow | -6,684 | -8,522 | -9,241 | -6,794 | -3,875 |
Capital Expenditure | -2,835 | -1,474 | -1,256 | -1,640 | -173 |
Free Cash Flow | -9,519 | -9,996 | -10,497 | -8,434 | -4,048 |